MedPath

A randomised controlled trial of Tranexamic acid in Intracerebral Haemorrhage (TICH) - Tranexamic acid in Intracerebral Haemorrhage (TICH)

Active, not recruiting
Conditions
Primary intracerebral haemorrhage
Registration Number
EUCTR2010-022009-16-GB
Lead Sponsor
niversity of Nottingham
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Adult patients with primary intracerebral haemorrhage confirmed on CT brain
Event <24 hours of onset (sleep stroke - onset as bed time)

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

•Secondary haemorrhagic stroke (anticoagulation, known vascular malformations)
•Previous venous thrombo-embolic disease
•Recent (within 12 months) ischaemic events (ischaemic stroke, myocardial infarction, peripheral artery disease)
•Renal impairment (eGRF <50mmols)
•Pregnancy or breast feeding
•Patients who are pregnant or breast feeding

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath